“We see improving dynamics for private healthcare (in China), supported by an ageing population, rising income and affordability funded by private medical insurance,” she adds. “Our channel checks and peer analysis show that healthcare can be profitable in China, notwithstanding near-term gestation costs.”
SINGAPORE (June 11): CGS-CIMB Research says China could be the “cure” for anaemic local growth among Singapore-listed healthcare providers, with a total healthcare market size that is some 46 times larger.
“China is an attractive market for Singapore healthcare companies,” says analyst Ngoh Yi Sin in a sector note on Monday. “China’s healthcare expenditure is projected to grow from RMB 5.3 trillion ($1.0 trillion) in 2017 to RMB 8.0 trillion in 2020F, but supply – especially private healthcare – still lags demand.”
